CG Oncology's stock has dropped 40% since its IPO peak, driven by profit-taking and competitive concerns despite promising ...

Cancer is a multifactorial disease that affects millions of individuals worldwide and has a profound impact on public health. The heterogeneity of solid ...

In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Castle Biosciences (CSTL – Research Report), with a price ...

Scotiabank analyst Sung Ji Nam maintained a Buy rating on Castle Biosciences (CSTL – Research Report) today and set a price target of $44.00.

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with ...

UltraMarathonRT® RT-qPCR Kit offers unmatched data reliability and sensitivity for gene expression studies, streamlining workflows and preserving RNA integrity.

Nasal epithelial gene expression can be used to characterize asthma endotypes and reveals that most participants from three ...